Prosecution Insights
Prosecution Insights
14 pending office actions • 9 art units • 11 examiners • 0 of 14 (0%) have an AI response strategy ready • 24 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 14 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 14 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 5 (36%) |
| §112 only | 2 (14%) |
| No statute on record | 7 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| POPA, ILEANA | 3 | 21.0% | +14.9% |
| MITCHELL, EDWIN COLEMAN | 2 | 33.3% | +65.1% |
| RONEY, CELESTE A | 1 | 62.3% | +18.0% |
| SHOMER, ISAAC | 1 | 63.1% | +30.7% |
| ANDERSON, REBECCA L | 1 | 73.2% | +24.0% |
| NGUYEN, QUANG | 1 | 38.2% | +52.8% |
| BURKHART, MICHAEL D | 1 | 62.4% | +10.9% |
| AUDET, MAURY A | 1 | 50.0% | +23.7% |
| POHNERT, STEVEN C | 1 | 12.1% | +18.3% |
| ARIETI, RUTH SOPHIA | 1 | 45.2% | +73.6% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17172527 | METHODS AND COMPOSITIONS FOR MESSENGER RNA PURIFICATION | POHNERT, STEVEN C | 96d overdue |
| 18431597 | Liver Specific Delivery of Messenger RNA | POPA, ILEANA | 29d overdue |
| 18334330 | LIVER SPECIFIC DELIVERY OF MESSENGER RNA | POPA, ILEANA | 29d overdue |
| 17450629 | PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLES | POPA, ILEANA | 9d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17292923 | METHODS FOR INDUCING IMMUNE TOLERANCE | BURKHART, MICHAEL D | 252d overdue |
| 17592335 | MRNA THERAPY FOR THE TREATMENT OF OCULAR DISEASES | NGUYEN, QUANG | 238d overdue |
| 17172527 | METHODS AND COMPOSITIONS FOR MESSENGER RNA PURIFICATION | POHNERT, STEVEN C | 96d overdue |
| 18431597 | Liver Specific Delivery of Messenger RNA | POPA, ILEANA | 29d overdue |
| 18334330 | LIVER SPECIFIC DELIVERY OF MESSENGER RNA | POPA, ILEANA | 29d overdue |
| 18575019 | COMPOSITIONS FOR DELIVERY OF MRNA | RONEY, CELESTE A | 22d overdue |
| 18246263 | PIPERAZINE-BASED CATIONIC LIPIDS | ANDERSON, REBECCA L | 18d overdue |
| 17055251 | Subcutaneous Delivery of Messenger RNA | ARIETI, RUTH SOPHIA | 5d |
| Art Unit | Apps |
|---|---|
| 1633 | 3 |
| 1612 | 2 |
| 1619 | 2 |
| 1635 | 2 |
| 1626 | 1 |
| 1631 | 1 |
| 1638 | 1 |
| 1654 | 1 |
| 1683 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18431597 | Liver Specific Delivery of Messenger RNA | POPA, ILEANA | 1633 | Other | Final Rejection | 29d overdue | Pending | Feb 02, 2024 |
| 18575019 | COMPOSITIONS FOR DELIVERY OF MRNA | RONEY, CELESTE A | 1612 | Other | Non-Final OA | 22d overdue | Pending | Dec 28, 2023 |
| 18555439 | "Good" buffer-based cationic lipids | SHOMER, ISAAC | 1612 | Other | Final Rejection | 9d | Pending | Oct 13, 2023 |
| 18334330 | LIVER SPECIFIC DELIVERY OF MESSENGER RNA | POPA, ILEANA | 1633 | §103 | Final Rejection | 29d overdue | Pending | Jun 13, 2023 |
| 18246263 | PIPERAZINE-BASED CATIONIC LIPIDS | ANDERSON, REBECCA L | 1626 | Other | Non-Final OA | 18d overdue | Pending | Mar 22, 2023 |
| 17592335 | MRNA THERAPY FOR THE TREATMENT OF OCULAR DISEASES | NGUYEN, QUANG | 1631 | §103 | Non-Final OA | 238d overdue | Pending | Feb 03, 2022 |
| 17534956 | Stable Liquid Lipid Nanoparticle Formulations | MITCHELL, EDWIN COLEMAN | 1619 | Other | Final Rejection | 47d | Pending | Nov 24, 2021 |
| 17611020 | IMPROVED PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLES | MITCHELL, EDWIN COLEMAN | 1619 | Other | Non-Final OA | 33d | Pending | Nov 12, 2021 |
| 17450629 | PROCESS OF PREPARING MRNA-LOADED LIPID NANOPARTICLES | POPA, ILEANA | 1633 | §103 | Final Rejection | 9d | Pending | Oct 12, 2021 |
| 17292923 | METHODS FOR INDUCING IMMUNE TOLERANCE | BURKHART, MICHAEL D | 1638 | §112 | Non-Final OA | 252d overdue | Pending | May 11, 2021 |
| 17291937 | 2,5-DIOXOPIPERAZINE LIPIDS WITH INTERCALATED ESTER, THIOESTER, DISULFIDE AND ANHYDRIDE MOIEITIES | AUDET, MAURY A | 1654 | §112 | Non-Final OA | 79d | Pending | May 06, 2021 |
| 17172527 | METHODS AND COMPOSITIONS FOR MESSENGER RNA PURIFICATION | POHNERT, STEVEN C | 1683 | §103 | Non-Final OA | 96d overdue | Pending | Feb 10, 2021 |
| 17055251 | Subcutaneous Delivery of Messenger RNA | ARIETI, RUTH SOPHIA | 1635 | Other | Final Rejection | 5d | Pending | Nov 13, 2020 |
| 17076195 | COMPOSITIONS, METHODS AND USES OF MESSENGER RNA | SHIN, DANA H | 1635 | §103 | Final Rejection | 71d overdue | Pending | Oct 21, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial